Eli Lilly And Sanofi

Rediff.com » News » Eli Lilly And Sanofi

News for Eli Lilly And Sanofi

Business

Pharma majors under fire over trial compensation

A Union health ministry probe has revealed that pharmaceutical majors conducting clinical trials in India have not given compensation to majority of the volunteers who died during the trials.Of the......

200 life-saving drugs to be cheaper

The National Pharmaceutical Pricing Authority (NPPA) has decided to revise the prices of over 200 life-saving medicines of wide-ranging therapeutic categories. While prices of a majority of these......

1 insulin price cap for all brands

The National Pharmaceutical Pricing Authority has imposed a blanket ceiling on the prices of insulin, irrespective of the brand.While the move is set to bring down insulin prices, it has left the......

MNC pharma firms eyeing duty relief

Eli Lilly and Co (India), Sanofi Aventis and Bristol Myers Squibb India Pvt are among the multinational pharmaceutical companies that are trying to get their products included in the duty exempted......

Consumers may have to pay more for insulin

Popular domestic brands of insulin analog Glargine (the chemical name) are in short supply for the past few months, forcing patients to switch to expensive imported alternatives, it is learnt.......

Eli Lilly And Sanofi

News for Eli Lilly And Sanofi

Pharma majors under fire over trial compensation

200 life-saving drugs to be cheaper

1 insulin price cap for all brands

MNC pharma firms eyeing duty relief

Consumers may have to pay more for insulin

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS